Explore chapters and articles related to this topic
Clinical and genomic characterisation of a fatal Puumala orthohantavirus case with low levels of neutralising antibodies
Published in Infectious Diseases, 2022
Anne Tuiskunen Bäck, Johan Rasmuson, Therese Thunberg, Gregory Rankin, Julia Wigren Byström, Charlotta Andersson, Andreas Sjödin, Mattias Forsell, Clas Ahlm
Puumala orthohantavirus (PUUV) is endemic in the Central and Northern Europe with a peak incidence of >300 cases per 100,000 inhabitants with an overall case-fatality rate of 0.4%, and 2–6% for elderly patients [3]. The symptoms include fever, headache, myalgia, abdominal pain, blurred vision and oliguria [1]. Thrombocytopenia and renal impairment are frequent and diagnostic for the disease. One third of diagnosed patients are hospitalised and may develop hypotension due to capillary leakage [4].